1. Home
  2. DTIL vs THRY Comparison

DTIL vs THRY Comparison

Compare DTIL & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$5.83

Market Cap

136.0M

Sector

Health Care

ML Signal

HOLD

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$2.79

Market Cap

114.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTIL
THRY
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
136.0M
114.8M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
DTIL
THRY
Price
$5.83
$2.79
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$60.00
$9.33
AVG Volume (30 Days)
336.9K
806.2K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.50
EPS
N/A
0.01
Revenue
$1,070,000,000.00
$785,015,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$34.75
N/A
P/E Ratio
N/A
$280.00
Revenue Growth
N/A
N/A
52 Week Low
$3.53
$1.91
52 Week High
$8.82
$15.49

Technical Indicators

Market Signals
Indicator
DTIL
THRY
Relative Strength Index (RSI) 54.21 44.63
Support Level $3.96 $2.47
Resistance Level $7.59 $3.69
Average True Range (ATR) 0.58 0.23
MACD -0.15 0.06
Stochastic Oscillator 21.03 59.32

Price Performance

Historical Comparison
DTIL
THRY

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

Share on Social Networks: